Skip to content
The Policy VaultThe Policy Vault

VivjoaUnited Healthcare

recurrent vulvovaginal candidiasis

Preferred products

  • fluconazole

Initial criteria

  • Diagnosis of recurrent vulvovaginal candidiasis
  • Patient is not of reproductive potential (i.e., biological female who is postmenopausal or has another reason for permanent infertility such as tubal ligation, hysterectomy, salpingo-oophorectomy)
  • Other causes (including but not limited to bacterial vaginosis or trichomoniasis) have been ruled out
  • Failure of a maintenance course of oral fluconazole defined as 100-mg, 150-mg, or 200-mg taken weekly for 6 months (Connecticut, Kentucky, and Mississippi only require a 30‑day trial)
  • Prescribed by or in consultation with an infectious disease physician OR obstetrician/gynecologist

Approval duration

4 months